Wheat (Triticum aestivum L.)
Disease resistance, drought tolerance, Composition - food (processing), Composition - food (human nutrition)
This licence allows the CSIRO to conduct a limited and controlled release of wheat genetically modified for disease resistance, drought tolerance, altered oil content and altered grain composition. The introduced genes are derived from wheat, with the other introduced genes derived from organisms that are routinely used in food and feed or that are widely present in the environment. The field trial is authorised to take place at two sites of up to 1 hectare each in the ACT and the Shire of Boorowa, New South Wales, for a period of five years. The GM wheat would not be used for commercial human food or animal feed.
The purpose of the field trial is to assess the agronomic characteristics of the GM wheat under field conditions. Control measures include conditions to ensure secure transport and storage of the GMOs, and at the end of the trial, require inspection of the site for wheat volunteers to ensure all GM plants are destroyed.
The risk analysis for this application was carried out in accordance with the Regulator’s Risk Analysis Framework.
Please see our factsheet for more information on GM wheat trials in Australia.
Outlines the Regulator’s decision to issue a licence following the assessment of this application.
FAQs on the licence application and the Regulator’s decision to issue a licence for this application.
A summary of the Risk Assessment and Risk Management Plan prepared as part of the assessment of this application. It provides a brief description of the licence application, the risk assessment and risk management plan.
The final risk assessment and management plan prepared to support the Regulator's decision. It describes the GMO(s) and proposed work with the GMO(s) and provides an assessment of potential risks posed by the GMO(s). It also includes a summary of submissions received during the public consultation process.